SCHEMBL11025720

SCHEMBL11025720

CN1CCN(c2ccc([O])cc2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.63
MAPT P10636 3/20 0.63
ALDH1A1 P00352 2/20 0.63
KMT2A Q03164 2/20 0.63
KDM4E B2RXH2 2/20 0.63
PTK2B Q14289 2/20 0.63
ADRA2C P18825 2/20 0.63
GFER P55789 1/20 0.63
ESR2 Q92731 1/20 0.63
SIRT6 Q8N6T7 1/20 0.58
LMNA P02545 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
TP53 P04637 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MEN1 O00255 1/20 0.52
GLA P06280 1/20 0.52
CHKA P35790 1/20 0.50
HTR3A P46098 1/20 0.50
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15489560 0.79 MAPT (0.65) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL81814 0.79 MAPT (0.65) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL6414948 0.77 MAPT (1.00) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL666629 0.77 MAPT (0.63) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL574836 0.77 MAPT (0.63) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL14922321 0.77 ALDH1A1 (0.63) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL19402 0.77 ALDH1A1 (0.63) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL56547 0.77 MAPT (1.00) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL21204496 0.77 MAPT (0.63) GAAMAPTALDH1A1KMT2AKDM4E
SCHEMBL1375430 0.77 LMNA (0.73) GAAMAPTALDH1A1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614065-B1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2017-04-19 EP disclosed
US-8541576-B2 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL (IT) 2013-09-24 US disclosed
US-20120190678-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190678-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS PIM1, PIM2, PIM3 GAA 1017/4885MAPT 2562/4885ALDH1A1 3389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.